Senti Biosciences stockholders approve merger with ST NewCo, reverse split

Senti Biosciences says stockholders approved its merger with ST NewCo and approved a reverse split ratio of 1-for-20 to 1-for-50.

Detected & updated continuously · Source: Nebula